In 2010, £16.1 billion was spent on research and development (R&D) undertaken across all UK business sectors, an increase of 3.7% on the previous year. Total R&D expenditure in 2010 represented 1.1% of GDP, in line with recent years.
Figure 1 – Sources of funds for pharmaceutical business R&D undertaken in the UK, 2010
UK-based pharmaceutical companies themselves funded the majority of business R&D in the UK, 65% of the total £4.6 billion. The second largest source of funding for R&D in the UK was from the parent/subsidiary companies operating outside the UK, 22% of the total.
Notes: These figures are industrial R&D only, and do not include charities or NHS.
Source: ONS UK Business Enterprise Research and Development, 2010